tiprankstipranks

Jinxin Fertility Group Reports Revenue Growth but Decline in Profits for 2024

Story Highlights
Jinxin Fertility Group Reports Revenue Growth but Decline in Profits for 2024

Confident Investing Starts Here:

Jinxin Fertility Group Ltd. ( (HK:1951) ) has issued an update.

Jinxin Fertility Group Ltd. reported a slight increase in revenue for the year ending December 31, 2024, reaching approximately RMB2,811.6 million, a 0.8% rise from the previous year. However, the company’s net profit saw a significant decline of 21.2% to RMB273.5 million. The board decided not to recommend a final dividend for the year, reflecting the financial challenges faced. The company provided non-IFRS financial measures to offer a clearer picture of its operational performance, despite the declines in adjusted net profit and EBITDA.

More about Jinxin Fertility Group Ltd.

Jinxin Fertility Group Ltd. operates in the fertility services industry, providing assisted reproductive services and related healthcare solutions. The company focuses on offering comprehensive fertility treatments and is listed on the Hong Kong Stock Exchange.

YTD Price Performance: 14.87%

Average Trading Volume: 72,949,222

Technical Sentiment Signal: Sell

Current Market Cap: HK$8.48B

See more data about 1951 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1